Company profile for Oragenics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Oragenics is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics, Inc. has established two exclusive worldwide channel collaborations with Intrexon Corporation Inc., a synthetic biology company. The collaborations allow Oragenics access to Intrexon's proprietary technologies toward the goal of accelerating the development of much need...
Oragenics is focused on becoming a leader in novel antibiotics against infectious disease and on developing effective treatments for oral mucositis. Oragenics, Inc. has established two exclusive worldwide channel collaborations with Intrexon Corporation Inc., a synthetic biology company. The collaborations allow Oragenics access to Intrexon's proprietary technologies toward the goal of accelerating the development of much needed new antibiotics that can work against resistant strains of bacteria and the development of biotherapeutics for oral mucositis and other diseases

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
4902 Eisenhower Blvd. Suite 125 Tampa, FL 33634
Telephone
Telephone
813-286-7900
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2025-10-21/oragenics-regains-full-nyse-american-compliance-company-resolves-stockholder-equity-deficiency

PHARMIWEB
21 Oct 2025

https://www.pharmiweb.com/press-release/2025-10-07/oragenics-announces-strategic-partnership-with-receptorai-to-accelerate-pipeline-development

PHARMIWEB
07 Oct 2025
Oragenics Q2 2025 Shareholder News
Oragenics Q2 2025 Shareholder News

11 Aug 2025

// GLOBENEWSWIRE

https://www.globenewswire.com/news-release/2025/08/11/3130934/0/en/Oragenics-Q2-2025-Shareholder-Update.html

GLOBENEWSWIRE
11 Aug 2025

https://www.globenewswire.com/news-release/2025/07/31/3125012/0/en/Oragenics-Selects-Southern-Star-Research-as-Clinical-Research-Organization-for-ONP-002-Phase-IIa-Trial.html

GLOBENEWSWIRE
31 Jul 2025

https://www.globenewswire.com/news-release/2025/07/16/3116417/0/en/Oragenics-Inc-Announces-U-S-Based-Drug-Manufacturing-Agreement-to-Support-ONP-002-Clinical-Development.html

GLOBENEWSWIRE
16 Jul 2025

https://www.globenewswire.com/news-release/2025/07/02/3109534/0/en/Oragenics-Completes-Approximately-16-5-Million-Offering.html

GLOBENEWSWIRE
02 Jul 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty